Sensitivity to Fas-mediated apoptosis is null or weak in B-cell non-Hodgkin's lymphomas and is moderately increased by CD40 ligation.

Por Xerri, L., Bouabdallah, R., Devilard, E., Hassoun, J., Stoppa, A. M., Birg, F.
Publicado em 1998

Evolution in the treatment of multiple myeloma and impact on dialysis independence: data from a French cohort from 1999 to 2014

Por Laforet, M, Jourde-Chiche, N, Haddad, F, Sallee, M, Stoppa, A M, Brunet, P, Dussol, B, Burtey, S, Gondouin, B
Publicado no Blood Cancer J (2016)

Pharmacokinetics of mitoxantrone in cancer patients treated by high-dose chemotherapy and autologous bone marrow transplantation.

Por Richard, B., Launay-Iliadis, M. C., Iliadis, A., Just-Landi, S., Blaise, D., Stoppa, A. M., Viens, P., Gaspard, M. H., Maraninchi, D., Cano, J. P.
Publicado em 1992

Benefit of continuous treatment for responders with newly diagnosed multiple myeloma in the randomized FIRST trial

Por Bahlis, N J, Corso, A, Mugge, L-O, Shen, Z-X, Desjardins, P, Stoppa, A-M, Decaux, O, de Revel, T, Granell, M, Marit, G, Nahi, H, Demuynck, H, Huang, S-Y, Basu, S, Guthrie, T H, Ervin-Haynes, A, Marek, J, Chen, G, Facon, T
Publicado no Leukemia (2017)